Navigation Links
Arcadia Resources Announces First Quarter Results

INDIANAPOLIS, Aug. 13 /PRNewswire-FirstCall/ -- Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of home care, medical staffing, and pharmacy services under the Arcadia HealthCare(SM) brand, today announced results for its fiscal first quarter ended June 30, 2009.

For the first quarter of fiscal 2010, Arcadia reported net revenues of $26.4 million compared with $26.8 million for the same period last year. Arcadia reported a net loss from continuing operations of $3.6 million, or $0.02 per share, in the current quarter compared to a net loss from continuing operations of $4.0 million, or $0.03 per share, for the fiscal 2009 first quarter. The consolidated net loss, including discontinued operations, was $4.6 million in the current quarter, or $0.03 per share, compared to a net loss of $3.3 million, or $0.03 per share, for the same period a year ago.

In its Pharmacy segment, Arcadia reported a $2.1 million increase in sales for its DailyMed(TM) medication management system in the quarter compared to the same period a year ago, and a $1.0 million, or 48.2% increase, over the fourth quarter of fiscal 2009. In its Services segment, the Company reported an increase in home care sales of 4.7% over the same period a year ago and a 1.6% increase over the prior quarter.

"This quarter marked our first under our new business structure focused on two core businesses," said Marvin R. Richardson, President and Chief Executive Officer of Arcadia. "During the past six months, our management team efforts have centered around the sale of non-core assets and restructuring our long-term debt, and we have emerged as a much more streamlined and focused company with an improved balance sheet and stronger growth prospects. Now we are concentrating on operational improvements in our Pharmacy and Home Care/Medical Staffing businesses to ensure our sales growth translates to solid margins and profitability."

Arcadia said it has commenced the DailyMed enrollment of high risk patients under its new agreement with WellPoint, which was announced during the first quarter. "Our rollout of the five-state program with WellPoint has started in the State of Virginia, and we are reaching out to more than 12,000 high-risk members that WellPoint has identified will most benefit from our DailyMed medication management program," Richardson said. "We are excited to introduce DailyMed to WellPoint's Medicaid members and believe the result will help improve member care and lower healthcare costs by more effectively managing chronic medication utilization and reducing unnecessary hospitalizations for their Medicaid members."

Fiscal 2010 First Quarter Results

Arcadia reported $26.4 million in revenue from continuing operations during the quarter, down slightly from $26.8 million during the same period a year ago. The Company's gross margin was 28.2% during the first quarter, a 2.1% decline from the same period a year ago. The reduction in gross margin occurred principally in the Pharmacy segment.

  • Pharmacy: Pharmacy segment revenues increased 191% to $3.2 million for the first quarter of fiscal 2010, compared to $1.1 million in revenues for the same quarter of fiscal 2009. Gross margins declined from 17.4% in the first quarter of fiscal 2009 to 11.0% in the most recent quarter. The Company said that first quarter margins were negatively impacted by certain one-time costs and expenses, including an inventory adjustment in its Minneapolis pharmacy. The Company said it has implemented purchasing and other margin improvement actions that will increase margins in the second quarter and subsequent periods.

  • Services: The Company's Services segment, which includes its home health care and medical staffing business, reported net revenues of $22.7 million for the quarter compared to net revenues of $25.0 million for the same period a year ago. Within the Services segment, home health care revenues increased by $0.8 million, or 4.7%, to $17.7 million, compared to net revenue of $16.9 million the same period last year. This increase was offset by the decline in medical staffing revenue to $5.0 million in the current quarter, compared with $8.1 million during the first quarter of fiscal 2009. Per diem staffing revenue and travel nurse staffing revenue declined 35% and 45%, respectively, compared to the same period a year ago. Gross margins remained constant at 30.5% compared with 30.4% for the same period last year.

Management's Outlook

"Our management team is focused on improving our operational performance in four key areas," said Steven Zeller, Arcadia's Chief Operating Officer. "These are growth in our Services revenue despite difficult medical staffing market conditions; enrolling and servicing our increasing population of DailyMed customers; improving our Pharmacy segment gross margins; and aligning our selling, general and administrative (SG&A) expenses with our current business focus and lower revenue base. While our first quarter results were mixed in these areas, we are making measurable progress and are confident we have the right plans in place to achieve our objectives during the course of the year."

In its Services segment, Arcadia is projecting that its fiscal 2010 revenue will range from $90 to $100 million, depending significantly on market conditions for medical staffing.

"We continue to see growth in our home care business despite overall economic conditions," Zeller said. "At the same time, we do see challenges in this segment, particularly in state-funded Medicaid programs, which are under severe budget pressures. Like others in the medical staffing industry, we experienced further declines in our medical staffing business during the first quarter, particularly in our travel nursing division. We expect to see some stabilization in this market over the next few quarters, although we do not expect any significant improvement in demand."

Commenting on the Pharmacy segment, Richardson said: "We continue to bring new payers and partners into the DailyMed program, and are also expanding the program organically with existing payers and partners. However, the fact that DailyMed represents a new and unique approach to managing medication compliance and health care costs makes it more difficult to project our sales in the Pharmacy segment versus our more traditional markets."

Arcadia said there are several key variables that will influence the timing of DailyMed revenue growth. These include the timing of new program roll-outs, the number of high-risk patients targeted and the rate of converting that targeted population into DailyMed enrollees.

"We currently expect that our second quarter DailyMed sales will grow in the range of 20% over the first quarter. Our revenue will accelerate starting later in the second quarter and into the third quarter as we ramp up our programs with WellPoint and others. Based on our current experience, we are projecting that our fiscal 2010 DailyMed sales will range between $25 and $35 million," Richardson said. "We should have better visibility after the second quarter as we expand our patient population and resulting data, and we look forward to updating our expectations at that time."

Arcadia said Pharmacy gross margins are a key operational focus area and it has already identified operational and purchasing improvements that are expected to result in sequential improvement in Pharmacy gross margin throughout the year.

Richardson continued: "We have invested significantly in the infrastructure and headcount to meet the increasing DailyMed demand over the past several quarters. We are now focused on driving the operational improvements and efficiency gains we know we can achieve. As a result, while we will add modestly to our Pharmacy SG&A expense as demand increases, we believe we will see SG&A as a percentage of sales decline significantly during the course of FY 2010.

"Likewise, in our corporate SG&A we continue to make progress on our cost reduction initiatives. After restructuring our business during the last six months, we have identified an additional $750,000 to $1 million in further cost reduction opportunities that we will implement over the course of the year."

Capital Resources and Liquidity

At June 30, 2009, the Company had $0.5 million in cash and cash equivalents on its balance sheet and had access to $2.5 million in additional line of credit availability, resulting in total cash and availability of $2.95 million, compared to total cash and availability of $4.5 million at March 31, 2009.

Arcadia reported negative cash flow from total operations of $1.6 million for the quarter, compared with cash generated from operations of $740,000 and $375,000 in the fourth quarter of fiscal 2009 and the same period a year ago, respectively.

"The reduction in operating cash flow quarter-over-quarter was primarily due to two factors. First, the ramp up of our Pharmacy operations and the higher operating loss in that segment resulted in negative operating cash flow," said Matthew Middendorf, Chief Financial Officer. "In addition, we include discontinued operations in our operating cash flow statement and our operating loss from discontinued operations was $1.2 million in the quarter, as compared with earnings of $0.7 million in the prior year quarter.

"During the quarter, we reached agreement with Comerica Bank to renew our existing senior credit facility, which was completed in July," added Middendorf. "We also significantly reduced our long-term indebtedness by more than $7 million during the quarter. We are actively working on a line of credit to support the growth of our Pharmacy segment and hope to complete that during the second quarter."

Conference Call Information

Arcadia will conduct a conference call and simultaneous Internet webcast to review these financial results on Thursday, August 13, 2009 at 11 a.m. Eastern Time.

To access the webcast, visit the Company's Web site at approximately 5-10 minutes prior to the start time and click on the webcast link. The webcast can also be accessed on

The conference call also may be accessed by telephone by dialing 1-877-407-0778 (for U.S.-based callers) or 1-201-689-8565 (for international callers).

A replay of the webcast will be available approximately one hour after the completion of the call and will be accessible on until November 14, 2009. A telephone replay will be available by dialing 1-877-660-6853 (for U.S.-based callers) or 1-201-612-7415 (for international callers). For the replay, callers must use both Passcode Account number 286 and Conference ID number 329853. The telephone replay will be available until August 27, 2009.

Use of Non-GAAP Financial Information

In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Arcadia reports non-GAAP financial results. Arcadia's management believes these non-GAAP measures are useful to investors because they provide supplemental information that facilitates comparisons to prior periods. Management uses these non-GAAP measures to evaluate its financial results, develop budgets and manage expenditures. The method Arcadia uses to produce non-GAAP results is likely to differ from the methods used by other companies and should not be regarded as a replacement for corresponding GAAP measures. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to the comparable GAAP results, which is attached to this release.

About Arcadia HealthCare

Arcadia HealthCare is a service mark of Arcadia Resources, Inc. (NYSE Amex: KAD), and is a leading provider of home care, medical staffing and pharmacy services under its proprietary DailyMed program. The Company, headquartered in Indianapolis, Indiana, has 72 locations in 21 states. Arcadia HealthCare's comprehensive solutions and business strategies support the Company's vision of "Keeping People at Home and Healthier Longer."

DailyMed(TM) Pharmacy dispenses a monthly cycle of a patient's prescriptions, over-the-counter medications and vitamins, and organizes them into pre-sorted packets clearly marked with the date and time the medications should be taken. In the dispensing process, a DailyMed pharmacist reviews each patient's medication profile and utilizes state-of-the-art medication therapy management tools in order to improve the safety and efficacy of the medications being dispensed. A DailyMed pharmacist provides routine communication with the patient, the primary care physician, caregivers and payers in order to maximize the pharmaceutical care administered. The DailyMed program improves patient care and drug utilization while reducing drug and hospitalization costs for private and government payers.

Forward Looking Statements

Any statements contained in this release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21A of the Securities Exchange Act of 1934, as amended and otherwise within the meaning of court opinions construing such forward-looking statements. The Company claims all safe harbor and other legal protections provided to it by law for all of its forward-looking statements. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, estimates, uncertainties and other factors, which could cause actual financial or operating results, performances or achievements expressed or implied by such forward-looking statements not to occur or be realized, including our estimates of consumer demand for our services and products, required capital investment, competition, and other factors. Actual events and results may differ materially from those expressed, implied or forecasted in forward-looking statements due to a number of factors. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the Company's filings with the Securities and Exchange Commission from time to time, including the section entitled "Risk Factors" and elsewhere in the Company's most recent Annual Report on Form 10-K and subsequent periodic reports. Among the factors that could cause future results to differ materially from those provided in our press release are: (i) we cannot be certain or our ability to generate sufficient cash flow to meet our obligations on a timely basis; (ii) we may be required to make significant business investments that do not produce offsetting increases in revenue; (iii) we may be unable to execute and implement our growth strategy; (iv) we may be unable to achieve our targeted performance goals for our business segments; and (v) other unforeseen events may impact our business. The forward-looking statements speak only as of the date hereof. The Company disclaims any obligation to update or alter its forward-looking statements, except as may be required by law.

                               ARCADIA RESOURCES, INC.
                         (IN THOUSANDS, EXCEPT SHARE AMOUNTS)

                                                         June 30,    March 31,
                                                            2009         2009
                                                            ----         ----
                        ASSETS                          (unaudited)
    Current assets:
     Cash and cash equivalents                              $517       $1,522
            Accounts receivable, net of allowance
             of $3,571 and $3,386, respectively           14,803       15,679
            Inventories, net                                 841          863
            Prepaid expenses and other current
             assets                                        1,577        1,764
            Current assets of discontinued
             operations                                      757        5,458
                                                             ---        -----
                 Total current assets                     18,495       25,286
    Property and equipment, net                            2,180        2,308
    Goodwill                                              17,053       17,053
    Acquired intangible assets, net                        8,146        8,305
    Other assets                                             629          590
    Restricted cash                                          500            -
    Assets of discontinued operations                         34        5,850
                                                              --        -----
                  Total assets                           $47,037      $59,392
                                                         =======      =======

    Current liabilities:
            Lines of credit, current portion                  $-         $437
            Accounts payable                               2,579        2,765
            Accrued expenses:
                Compensation and related taxes             2,662        2,986
                Interest                                      41           89
                Health insurance                             524          545
                Other                                      1,046          917
            Payable to affiliated agencies                   809        1,284
            Long-term obligations, current portion         1,235          596
            Capital lease obligations, current
             portion                                          73           59
            Current liabilities of discontinued
             operations                                    1,064        2,037
                                                           -----        -----
                   Total current liabilities              10,033       11,715
    Lines of credit, less current portion                  7,749       10,889
    Long-term obligations, less current
     portion                                              23,646       26,918
    Capital lease obligations, less current
     portion                                                  64           37
                                                              --           --
                   Total liabilities                      41,492       49,559
                                                          ------       ------

    Commitments and contingencies

    Preferred stock, $.001 par value,
     5,000,000 shares authorized, none
     outstanding                                               -            -
    Common stock, $.001 par value,
     200,000,000 shares authorized;
     161,291,415 shares and 161,249,529
     shares issued, respectively                             161          161
    Additional paid-in capital                           136,205      135,920
    Accumulated deficit                                 (130,821)    (126,248)
                                                        --------     --------
                  Total stockholders' equity               5,545        9,833
                                                           -----        -----
                  Total liabilities and stockholders'
                   equity                                $47,037      $59,392
                                                         =======      =======

                               ARCADIA RESOURCES, INC.
                        (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

                                                   Three Month Period Ended
                                                            June 30,
                                                       2009             2008
                                                       ----             ----

    Revenues, net                                   $26,409          $26,778
    Cost of revenues                                 18,961           18,668
                                                     ------           ------
               Gross profit                           7,448            8,110

    Selling, general and administrative               9,666           10,244
    Depreciation and amortization                       411              459
                                                        ---              ---
      Total operating expenses                       10,077           10,703

               Operating loss                        (2,629)          (2,593)

    Other expenses:
            Interest expense, net                       838              956
            Loss on extinguishment of debt                -              248
            Other                                        36               10
                                                         --               --
               Total other expenses                     874            1,214
                                                        ---            -----

         Loss from continuing operations
          before income taxes                        (3,503)          (3,807)

    Income tax expense                                   93              196
                                                         --              ---
               Loss from continuing operations       (3,596)          (4,003)

    Discontinued operations:
            Income / (loss) from discontinued
             operations                              (1,193)             717
            Net gain on disposal                        216                -
                                                        ---                -
                                                       (977)             717
                                                       ----              ---

    NET LOSS                                        $(4,573)         $(3,286)
                                                    =======          =======

    Weighted average number of common
     shares outstanding                             160,552          131,688

    Basic and diluted net loss per
    Loss from continuing operations                  $(0.02)          $(0.03)
    Loss from discontinued operations                 (0.01)               -
                                                      -----                -
    Net loss per share                               $(0.03)          $(0.03)
                                                     ======           ======

                               ARCADIA RESOURCES, INC.
                                 (IN THOUSANDS)

                                              Three-Month Period Ended
                                                      June 30,
                                                  2009          2008
                                                  ----          ----
    Operating activities
    Net loss for the period                    $(4,573)      $(3,286)
    Adjustments to reconcile net loss to
     net cash provided by (used in)
     operating activities:
      Provision for doubtful accounts              873           811
      Depreciation of property and
       equipment                                   531         1,012
      Amortization of intangible assets            246           456
      Gain on business disposals                  (216)            -
      Non-cash interest expense                    584
      Loss on sale of property and
       equipment                                     -            10
      Amortization of deferred financing
       costs and debt discounts                     52           246
      Stock-based compensation expense             285           401
    Changes in operating assets and
     liabilities, net of acquisitions:
      Accounts receivable                        1,750          (792)
      Inventories                                  639          (228)
      Other assets                                 233         1,176
      Accounts payable                            (547)          (63)
      Accrued expenses                          (1,146)          625
      Due to affiliated agencies                  (327)           16
      Deferred revenue                               -            (9)
                                                     -            --
    Net cash provided by (used in)
     operating activities                       (1,616)          375
                                                ------           ---

    Investing activities
    Business acquisitions, net of cash
     acquired                                     (190)         (363)
    Proceeds from business disposal              9,157             -
    Increase in restricted cash                   (500)            -
    Proceeds from disposals of property
     and equipment                                   -            19
    Purchases of property and equipment            (75)         (264)
                                                   ---          ----
    Net cash provided by (used in)
     investing activities                        8,392          (608)
                                                 -----          ----

    Financing activities
    Net payments on lines of credit             (3,577)       (3,299)
    Payments on notes payable and
     capital lease obligations                  (4,204)         (438)
                                                ------          ----
    Net cash used in financing
     activities                                 (7,781)       (3,737)
                                                ------        ------

    Net change in cash and cash
     equivalents                                (1,005)       (3,970)
    Cash and cash equivalents, beginning
     of period                                   1,522         6,351
                                                 -----         -----
    Cash and cash equivalents, end of
     period                                       $517        $2,381
                                                  ====        ======

SOURCE Arcadia Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arcadia Completes New Financing; Previews Fourth Quarter Results
2. Arcadia Resources Announces Sale of Non-Strategic Businesses
3. Plane Crash Claims Arcadians Chairman and Founder, John H. Austin M.D.
4. Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth-Quarter and Year-End Conference Call
5. Arcadia Resources Sells Non-Core Software Business
6. Arcadian Management Services Names CEO Robert Fahlman as Chairman of the Board
7. Arcadia Resources Responds to Share Price Volatility
8. Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed(TM) Pharmacy Operations
9. WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members
10. Arcadia Resources Announces Fourth Quarter and Fiscal 2009 Year-End Results
11. Arcadian Chairman and Chief Executive Officer, Robert Fahlman, to Present at Focus on Healthcare Conference in New York City
Post Your Comments:
(Date:11/29/2015)... ... , ... Khanna Vision Institute based in Los Angeles, announced that Dr. Khanna ... Peer Certification by the Board is done so the public knows that the Doctor ... after the completion of three years of training or Residency in Ophthalmology. This is ...
(Date:11/29/2015)... ... , ... Key Housing, a top-rated corporate housing service for the San Jose ... Epic. In showcasing this featured apartment community in San Jose, Key Housing is helping ... efficiently find housing suitable to their needs by showcasing quality housing. , “San Jose ...
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology: